Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-25 @ 9:46 PM
Study NCT ID:
NCT00062751
Status:
COMPLETED
Last Update Posted:
2011-04-15
First Post:
2003-06-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-12
Start Date Type:
None
Primary Completion Date:
2005-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10
Completion Date Type:
ACTUAL
First Submit Date:
2003-06-12
First Submit QC Date:
None
Study First Post Date:
2003-06-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-10-27
Results First Submit QC Date:
None
Results First Post Date:
2010-11-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-04-13
Last Update Post Date:
2011-04-15
Last Update Post Date Type:
ESTIMATED